Latest United States Startup Funding Rounds

Startup funding in United States: recent rounds, the companies behind them and their participating investors.

This page showsCountry: United States
Rounds
2,130
Jan 1 – Oct 9, 2026
Disclosed funding
$200B
1764 disclosed amounts
Median round
$24M
Of disclosed amounts
2,130 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
EubricsAI · United StatesCompany profile

An AI sales enablement platform helps teams rehearse customer conversations, get live guidance and improve from call analytics.

An AI sales enablement platform helps teams rehearse customer conversations, get live guidance and improve from call analytics.

UndisclosedPre-seedAIUnited StatesInvestors
Verily HealthHealthtech · United StatesCompany profile

An AI-native precision-health platform organizes complex health data for research, care and personalized health services.

An AI-native precision-health platform organizes complex health data for research, care and personalized health services.

UndisclosedMarch financing extensionUndisclosedHealthtechUnited StatesInvestors
Moneyball.aiFintech · United StatesCompany profile

AI deal-team software helps boutique investment banks match deals to investors and manage outreach through closing.

AI deal-team software helps boutique investment banks match deals to investors and manage outreach through closing.

UndisclosedPre-seedFintechUnited StatesInvestors
VideoGenAI · United StatesCompany profile

AI video-creation software that helps creators, businesses and teams turn briefs or source media into editable, localized videos.

AI video-creation software that helps creators, businesses and teams turn briefs or source media into editable, localized videos.

$3.3MSeedAIUnited StatesInvestors
LatitudeFintech · United StatesCompany profile

Provides payment infrastructure connecting stablecoins with local currencies and payment networks.

Provides payment infrastructure connecting stablecoins with local currencies and payment networks.

$35MSeries AFintechUnited StatesInvestors
Solstice OncologyBiotech · United StatesCompany profile

A clinical-stage immunotherapy company is advancing an engineered CTLA-4 antibody for earlier cancer treatment.

A clinical-stage immunotherapy company is advancing an engineered CTLA-4 antibody for earlier cancer treatment.

$225MSeries ABiotechUnited StatesInvestors
Celero CommunicationsHardware · United StatesCompany profile

Celero develops coherent digital signal processors and analog technology for optical links that connect AI accelerators and data centers. Its validated 2nm silicon architecture is designed to move more data across scale-up, scale-out and data-center links with lower power and a path from 1.6T to next-generation 3.2T connectivity.

Celero develops coherent digital signal processors and analog technology for optical links that connect AI accelerators and data centers. Its validated 2nm silicon architecture is designed to move more data across scale-up, scale-out and data-center links with lower power and a path from 1.6T to next-generation 3.2T connectivity.

$275MSeries CSeries C+HardwareUnited StatesInvestors
LightsageAI · United StatesCompany profile

An agent-led growth platform measures whether AI agents can discover, evaluate and successfully use a company’s software.

An agent-led growth platform measures whether AI agents can discover, evaluate and successfully use a company’s software.

$4MFundingUndisclosedAIUnited StatesInvestors
ClaimQI, Inc.Healthtech · United StatesCompany profile

Claims-intelligence software that helps health plans review and prevent improper payments against coverage rules and policy language.

Claims-intelligence software that helps health plans review and prevent improper payments against coverage rules and policy language.

~$500KSeedHealthtechUnited StatesInvestors
Encoded Therapeutics Inc.Biotech · United StatesCompany profile

Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.

Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.

$275MSeries FSeries C+BiotechUnited StatesInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · From Jan 1, 2026

  1. 1
    Y Combinator (YC)

    Nous Research, Santé, Vitalize

    125rounds
    3led
  2. 2
    Andreessen Horowitz (a16z)

    TypeSafe AI, Arena, Vesta

    94rounds
    18led
  3. 3
    General Catalyst

    Minerva Humanoids, Melius

    65rounds
    6led
  4. 4
    Alumni Ventures

    Savvy Wealth, Mona, American Supercritical

    55rounds
    0led
  5. 5
    Khosla Ventures

    Arena, Vinci, Conway Research

    54rounds
    5led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic